The healthcare landscape has given Medical Affairs a critical function in optimizing the trajectory of product launch and traversing market complexities. In response to those same market pressures, we have seen a change in Clinical Operations that heralds an expansion in the role of Medical Affairs to include greater and closer involvement in the clinical development process.
This evolution necessitates a strong strategic partnership between Medical Affairs and Clinical organizations in order to capitalize on synergistic strengths and drive toward a shared goal to develop, differentiate and deliver products that improve patients’ lives.
This articled discusses how a strengthened Clinical-Medical Affairs partnership model can help life sciences partners to face the intense pressure to accelerate product approval timelines and respond to evolving requirements for successful product commercialization.
Download the article now.
